{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:57:38Z","timestamp":1793818658778,"version":"4.6.1"},"reference-count":211,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>This article provides an overview of the use of 18F-FDG PET\/CT in various clinical scenarios of head\u2013neck squamous cell carcinoma, ranging from initial staging to treatment-response assessment, and post-therapy follow-up, with a focus on the current evidence, debated issues, and innovative applications. Methodological aspects and the most frequent pitfalls in head\u2013neck imaging interpretation are described. In the initial work-up, 18F-FDG PET\/CT is recommended in patients with metastatic cervical lymphadenectomy and occult primary tumor; moreover, it is a well-established imaging tool for detecting cervical nodal involvement, distant metastases, and synchronous primary tumors. Various 18F-FDG pre-treatment parameters show prognostic value in terms of disease progression and overall survival. In this scenario, an emerging role is played by radiomics and machine learning. For radiation-treatment planning, 18F-FDG PET\/CT provides an accurate delineation of target volumes and treatment adaptation. Due to its high negative predictive value, 18F-FDG PET\/CT, performed at least 12 weeks after the completion of chemoradiotherapy, can prevent unnecessary neck dissections. In addition to radiomics and machine learning, emerging applications include PET\/MRI, which combines the high soft-tissue contrast of MRI with the metabolic information of PET, and the use of PET radiopharmaceuticals other than 18F-FDG, which can answer specific clinical needs.<\/jats:p>","DOI":"10.3390\/cancers16101905","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T11:26:17Z","timestamp":1715858777000},"page":"1905","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Role of 18F-FDG PET\/CT in Head and Neck Squamous Cell Carcinoma: Current Evidence and Innovative Applications"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1047-3333","authenticated-orcid":false,"given":"Carmelo","family":"Caldarella","sequence":"first","affiliation":[{"name":"Nuclear Medicine Unit, Department of Radiology and Oncologic Radiotherapy, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"De Risi","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Department of Radiology and Oncologic Radiotherapy, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Massaccesi","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Department of Radiology and Oncologic Radiotherapy, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Miccich\u00e8","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Ospedale Isola Tiberina\u2014Gemelli Isola, 00186 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6261-2772","authenticated-orcid":false,"given":"Francesco","family":"Bussu","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology Operative Unit, Azienda Ospedaliero Universitaria Sassari, 07100 Sassari, Italy"},{"name":"Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Galli","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology Unit, Department of Neurosciences, Sensory Organs and Thorax, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Section of Otolaryngology, Department of Head-Neck and Sensory Organs, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1045-0633","authenticated-orcid":false,"given":"Vittoria","family":"Rufini","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Department of Radiology and Oncologic Radiotherapy, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Section of Nuclear Medicine, Department of Radiological Sciences and Hematology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6000-2898","authenticated-orcid":false,"given":"Lucia","family":"Leccisotti","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Department of Radiology and Oncologic Radiotherapy, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Section of Nuclear Medicine, Department of Radiological Sciences and Hematology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","article-title":"Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Machiels","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_2","unstructured":"National Comprehensive Cancer Network (2024, March 25). NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers (Version 3.2024). Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Arboleda, L.P.A., de Carvalho, G.B., Santos-Silva, A.R., Fernandes, G.A., Vartanian, J.G., Conway, D.I., Virani, S., Brennan, P., Kowalski, L.P., and Curado, M.P. (2023). Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide. Cancers, 15.","DOI":"10.3390\/cancers15174405"},{"key":"ref_4","unstructured":"Eyassu, E., and Young, M. (2024). StatPearls [Internet], StatPearls Publishing."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/ERC-21-0359","article-title":"Head\/neck paragangliomas: Focus on tumor location, mutational status and plasma methoxytyramine","volume":"29","author":"Richter","year":"2022","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jamaoto.2015.3934","article-title":"Accuracy of Ultrasonography-Guided Fine-Needle Aspiration in Detecting Persistent Nodal Disease After Chemoradiotherapy","volume":"142","author":"Fleischman","year":"2016","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"105453","DOI":"10.1016\/j.oraloncology.2021.105453","article-title":"Comparison of different diagnostic imaging techniques for the detection of bone invasion in oral cancers","volume":"120","author":"Kouketsu","year":"2021","journal-title":"Oral Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4329\/wjr.v6.i5.177","article-title":"Role of 18F-FDG PET\/CT in pre and post treatment evaluation in head and neck carcinoma","volume":"6","author":"Tantiwongkosi","year":"2014","journal-title":"World J. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Liao, L.J., Lo, W.C., Hsu, W.L., Wang, C.T., and Lai, M.S. (2012). Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-236"},{"key":"ref_10","first-page":"1","article-title":"Role of 18F-FDG PET-CT in head and neck squamous cell carcinoma","volume":"33","author":"Castaldi","year":"2013","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1097\/RLU.0000000000002247","article-title":"Update 2018: 18F-FDG PET\/CT and PET\/MRI in Head and Neck Cancer","volume":"43","author":"Sanli","year":"2018","journal-title":"Clin. Nucl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/j.semnuclmed.2020.09.004","article-title":"PET-CT for Staging and Detection of Recurrence of Head and Neck Cancer","volume":"51","author":"Wong","year":"2021","journal-title":"Semin. Nucl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cpet.2023.12.013","article-title":"Quarter Century Positron Emission Tomography\/Computed Tomography Transformation of Oncology: Head and Neck Cancer","volume":"19","author":"Subramaniam","year":"2024","journal-title":"PET Clin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-NECK Trial Management Group. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer","volume":"374","author":"Mehanna","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamaoto.2020.0014","article-title":"Evaluation of the Prognostic Value of FDG PET\/CT Parameters for Patients with Surgically Treated Head and Neck Cancer: A Systematic Review","volume":"146","author":"Creff","year":"2020","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1200\/JCO.20.00275","article-title":"Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline","volume":"38","author":"Maghami","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40336-021-00429-w","article-title":"Performance of 18F-FDG-PET\/CT as a next step in the search of occult primary tumors for patients with head and neck squamous cell carcinoma of unknown primary: A systematic review and meta-analysis","volume":"9","author":"Huasong","year":"2021","journal-title":"Clin. Transl. Imaging"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00259-018-3978-3","article-title":"FDG-PET\/CT for treatment response assessment in head and neck squamous cell carcinoma: A systematic review and meta-analysis of diagnostic performance","volume":"45","author":"Helsen","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.semnuclmed.2020.07.008","article-title":"Role of Non-FDG-PET\/CT in Head and Neck Cancer","volume":"51","author":"Marcus","year":"2021","journal-title":"Semin. Nucl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2022.03.021","article-title":"Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [18F]FMISO PET\/CT","volume":"171","author":"Welz","year":"2022","journal-title":"Radiother. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2967\/jnumed.121.262831","article-title":"Head-to-Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET\/CT for Evaluation of Head and Neck Squamous Cell Carcinoma: A Single-Center Exploratory Study","volume":"63","author":"Promteangtrong","year":"2022","journal-title":"J. Nucl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0360-3016(95)00007-L","article-title":"Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and [11C]methionine","volume":"32","author":"Lindholm","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/coa.13242","article-title":"Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?","volume":"44","author":"Wedman","year":"2019","journal-title":"Clin. Otolaryngol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.21873\/anticanres.12708","article-title":"Hybrid Imaging PET\/CT with Application of 18F-Fluorothymidine in Patients with Head and Neck Carcinoma Undergoing Radiotherapy","volume":"38","author":"Baxa","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2967\/jnumed.115.161018","article-title":"68Ga-DOTATATE PET\/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT\/MRI","volume":"57","author":"Janssen","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2967\/jnumed.120.242305","article-title":"Benefit of improved performance with state-of-the art digital PET\/CT for lesion detection in oncology","volume":"61","author":"Surti","year":"2020","journal-title":"J. Nucl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejmp.2020.10.031","article-title":"Update on latest advances in time-of-flight PET","volume":"80","author":"Surti","year":"2020","journal-title":"Phys. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3389\/fonc.2020.01458","article-title":"Quality Assessment in FDG-PET\/CT Imaging of Head-and-Neck Cancer: One Home Run Is Better Than Two Doubles","volume":"10","author":"Carp","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/j.semnuclmed.2021.10.004","article-title":"Digital PET vs Analog PET: Clinical Implications?","volume":"52","author":"Flotats","year":"2022","journal-title":"Semin. Nucl. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2967\/jnumed.116.184028","article-title":"Total-body PET: Maximizing sensitivity to create new opportunities for clinical research and patient care","volume":"59","author":"Cherry","year":"2018","journal-title":"J. Nucl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2967\/jnumed.119.226498","article-title":"First human imaging studies with the EXPLORER total-body PET scanner","volume":"60","author":"Badawi","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1007\/s00259-021-05461-6","article-title":"Long axial field of view PET scanners: A road map to implementation and new possibilities","volume":"48","author":"Slart","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Roya, M., Mostafapour, S., Mohr, P., Provid\u00eancia, L., Li, Z., van Snick, J.H., Brouwers, A.H., Noordzij, W., Willemsen, A.T.M., and Dierckx, R.A.J.O. (2023). Current and Future Use of Long Axial Field-of-View Positron Emission Tomography\/Computed Tomography Scanners in Clinical Oncology. Cancers, 15.","DOI":"10.3390\/cancers15215173"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s00259-023-06516-6","article-title":"The clinical acceptability of short versus long duration acquisitions for head and neck cancer using long-axial field-of-view PET\/CT: A retrospective evaluation","volume":"51","author":"Mei","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2214\/AJR.22.28120","article-title":"Contemporary Imaging and Reporting Strategies for Head and Neck Cancer: MRI, FDG PET\/MRI, NI-RADS, and Carcinoma of Unknown Primary-AJR Expert Panel Narrative Review","volume":"220","author":"Mukherjee","year":"2023","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"16181","DOI":"10.1002\/cam4.6278","article-title":"A systematic review and meta-analysis of predictive and prognostic models for outcome prediction using positron emission tomography radiomics in head and neck squamous cell carcinoma patients","volume":"12","author":"Philip","year":"2023","journal-title":"Cancer Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Illimoottil, M., and Ginat, D. (2023). Recent Advances in Deep Learning and Medical Imaging for Head and Neck Cancer Treatment: MRI, CT, and PET Scans. Cancers, 15.","DOI":"10.3390\/cancers15133267"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"European Association of Nuclear Medicine (EANM). FDG PET\/CT: EANM procedure guidelines for tumour imaging: Version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00259-009-1127-8","article-title":"Staging primary head and neck cancers with 18F-FDG PET\/CT: Is intravenous contrast administration really necessary?","volume":"36","author":"Yoshida","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1470-7330-14-10","article-title":"Contrast-enhanced [18\u2009F] fluorodeoxyglucose-positron emission tomography\/computed tomography in clinical oncology: Tumor-, site-, and question-based comparison with standard positron emission tomography\/computed tomography","volume":"14","author":"Morbelli","year":"2014","journal-title":"Cancer Imaging"},{"key":"ref_41","first-page":"25S","article-title":"Acquisition protocol considerations for combined PET\/CT imaging","volume":"45","author":"Beyer","year":"2004","journal-title":"J. Nucl. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1148\/radiol.2433060043","article-title":"Head and neck cancer: Dedicated FDG PET\/CT protocol for detection-phantom and initial clinical studies","volume":"244","author":"Yamamoto","year":"2007","journal-title":"Radiology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nic.2021.09.003","article-title":"PET\/CT and PET\/MR Imaging of the Post-treatment Head and Neck: Traps and Tips","volume":"32","author":"Ivanidze","year":"2022","journal-title":"Neuroimaging Clin. N. Am."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/j.semnuclmed.2021.03.002","article-title":"PET\/CT Variants and Pitfalls in Head and Neck Cancers Including Thyroid Cancer","volume":"51","author":"Mihailovic","year":"2021","journal-title":"Semin. Nucl. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjoto.2014.11.008","article-title":"Positron emission tomography in Warthin\u2019s tumor mimicking malignancy impacts the evaluation of head and neck patients","volume":"36","author":"Rassekh","year":"2015","journal-title":"Am. J. Otolaryngol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2967\/jnumed.118.214312","article-title":"An Imager\u2019s Guide to Perineural Tumor Spread in Head and Neck Cancers: Radiologic Footprints on 18F-FDG PET, with CT and MRI Correlates","volume":"60","author":"Lee","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2214\/AJR.17.18301","article-title":"Clinical Practice in PET\/CT for the Management of Head and Neck Squamous Cell Cancer","volume":"209","author":"Goel","year":"2017","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00330-015-3902-1","article-title":"FDG-PET\/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: Comparison with FDG-PET\/non-contrast-enhanced CT and contrast-enhanced CT","volume":"26","author":"Suenaga","year":"2016","journal-title":"Eur. Radiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/ijnm.IJNM_119_19","article-title":"Does Intravenous Contrast Improve the Diagnostic Yield of Fluorodeoxyglucose Positron-emission Tomography\/Computed Tomography in Patients with Head-and-neck Malignancy","volume":"35","author":"Barai","year":"2020","journal-title":"Indian J. Nucl. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hed.20734","article-title":"Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study","volume":"30","author":"Johansen","year":"2008","journal-title":"Head Neck"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.canep.2012.03.002","article-title":"Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary","volume":"3","author":"Han","year":"2012","journal-title":"Cancer Epidemiol."},{"key":"ref_52","first-page":"89","article-title":"PET\/CT in the management of metastatic cervical lymphadenopathy from unknown primary site: A seven years retrospective study","volume":"134","author":"Barbosa","year":"2013","journal-title":"Rev. Laryngol. Otol. Rhinol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/0036933013496958","article-title":"The role of 18F-fluoro-2-deoxyglucose positron emission tomography\/computed tomography in the management of patients with carcinoma of unknown primary","volume":"5","author":"Deonarine","year":"2013","journal-title":"Scott. Med. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.clon.2023.03.012","article-title":"Imaging of Neck Nodes in Head and Neck Cancers\u2014A Comprehensive Update","volume":"35","author":"Bhattacharya","year":"2023","journal-title":"Clin. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e1191","DOI":"10.1097\/MLG.0b013e31816e2eb7","article-title":"The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma","volume":"118","author":"Gourin","year":"2008","journal-title":"Laryngoscope"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.semnuclmed.2020.07.009","article-title":"PET\/CT in Surgical Planning for Head and Neck Cancer","volume":"51","author":"Strohl","year":"2021","journal-title":"Semin. Nucl. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/hed.21622","article-title":"Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the N0 neck in patients with oral squamous cell carcinoma","volume":"33","author":"Murer","year":"2011","journal-title":"Head Neck"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"106070","DOI":"10.1016\/j.oraloncology.2022.106070","article-title":"Sentinel node biopsy in node negative early oral cancers: Solution to the conundrum!","volume":"134","author":"Vaish","year":"2022","journal-title":"Oral Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1245\/ASO.2005.11.024","article-title":"The second international conference on sentinel node biopsy in mucosal head and neck cancer","volume":"12","author":"Stoeckli","year":"2005","journal-title":"Ann. Surg. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ijom.2021.01.020","article-title":"Diagnostic yield of sentinel lymph node biopsy in oral squamous cell carcinoma T1\/T2-N0: Systematic review and meta-analysis","volume":"50","year":"2021","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1200\/JCO.20.01661","article-title":"Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0. Oral and Oropharyngeal Cancer","volume":"38","author":"Garrel","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1200\/JCO.20.03637","article-title":"HNCMM Research Group. Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial","volume":"39","author":"Hasegawa","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/jnci\/djn125","article-title":"18F-Fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: A meta-analysis","volume":"100","author":"Kyzas","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1148\/radiol.2015150959","article-title":"18F FDG PET\/CT versus CT\/MR Imaging and the Prognostic Value of Contralateral Neck Metastases in Patients with Head and Neck Squamous Cell Carcinoma","volume":"279","author":"Park","year":"2016","journal-title":"Radiology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1002\/lary.21650","article-title":"PET-CT staging of the neck in cancers of the oropharynx: Patterns of regional and retropharyngeal nodal metastasis","volume":"120","author":"Tauzin","year":"2010","journal-title":"Laryngoscope"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/00016489.2023.2179662","article-title":"New standards for the management of nose vestibule malignancies","volume":"143","author":"Bussu","year":"2023","journal-title":"Acta Otolaryngol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.14639\/0392-100X-N2786","article-title":"Management of nasal vestibule carcinomas: Recommendations by the Oncological Committee of the Italian Society of Otorhinolaryngology\u2014Head and Neck Surgery","volume":"44","author":"Bussu","year":"2024","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/hed.21447","article-title":"Contrast-enhanced 18F-FDG-PET\/CT for the assessment of necrotic lymph node metastases","volume":"33","author":"Haerle","year":"2011","journal-title":"Head Neck"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1148\/radiol.13131470","article-title":"18F fluorodeoxyglucose PET\/CT in head and neck squamous cell carcinoma with negative neck palpation findings: A prospective study","volume":"271","author":"Roh","year":"2014","journal-title":"Radiology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1200\/JCO.18.01182","article-title":"Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685","volume":"37","author":"Lowe","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/0194599820969104","article-title":"FDG-PET\/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG-PET\/CT cN0","volume":"164","author":"Stack","year":"2021","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2967\/jnumed.113.133892","article-title":"Ultra staging to unmask the prescribing of adjuvant therapy in cancer patients: The future opportunity to image micrometastases using total-body 18F-FDG PET scanning","volume":"55","author":"Price","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2018.2.FOCUS17761","article-title":"Brain metastasis from squamous cell carcinoma of the head and neck: A review of the literature in the genomic era","volume":"44","author":"Barrett","year":"2018","journal-title":"Neurosurg. Focus"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"znad377","DOI":"10.1093\/bjs\/znad377","article-title":"Correlation between second and first primary cancer: Systematic review and meta-analysis of 9 million cancer patients","volume":"111","author":"Wang","year":"2024","journal-title":"Br. J. Surg."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/hed.23033","article-title":"Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers","volume":"35","author":"Peck","year":"2013","journal-title":"Head Neck"},{"key":"ref_76","first-page":"752","article-title":"Detection of unexpected additional primary malignancies with PET\/CT","volume":"46","author":"Ishimori","year":"2005","journal-title":"J. Nucl. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hed.21184","article-title":"18F-FDG-PET\/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma","volume":"32","author":"Haerle","year":"2010","journal-title":"Head Neck"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pathol.2023.11.005","article-title":"Prognostic and predictive biomarkers in head and neck cancer: Something old, something new, something borrowed, something blue and a sixpence in your shoe","volume":"56","author":"Balgobind","year":"2024","journal-title":"Pathology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00259-010-1713-9","article-title":"A new dimension of FDG-PET interpretation: Assessment of tumor biology","volume":"38","author":"Kwee","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/hed.25591","article-title":"HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice","volume":"41","author":"Bussu","year":"2019","journal-title":"Head Neck"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2014.04.044","article-title":"Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: Detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators\u2014A pilot study","volume":"89","author":"Bussu","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Bussu, F., Muresu, N., Crescio, C., Gallus, R., Rizzo, D., Cossu, A., Sechi, I., Fedeli, M., Cossu, A., and Delogu, G. (2022). Low Prevalence of HPV Related Oropharyngeal Carcinogenesis in Northern Sardinia. Cancers, 14.","DOI":"10.3390\/cancers14174205"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Gallus, R., Nauta, I.H., Marklund, L., Rizzo, D., Crescio, C., Mureddu, L., Tropiano, P., Delogu, G., and Bussu, F. (2023). Accuracy of p16 IHC in Classifying HPV-Driven OPSCC in Different Populations. Cancers, 15.","DOI":"10.3390\/cancers15030656"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.canrad.2020.06.017","article-title":"PET and MRI guided adaptive radiotherapy: Rational, feasibility and benefit","volume":"24","author":"Thureau","year":"2020","journal-title":"Cancer Radiother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.radonc.2018.04.020","article-title":"Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation","volume":"128","author":"Vogel","year":"2018","journal-title":"Radiother. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"van den Bosch, S., Dijkema, T., Kunze-Busch, M.C., Terhaard, C.H., Raaijmakers, C.P., Doornaert, P.A., Hoebers, F.J., Vergeer, M.R., Kreike, B., and Wijers, O.B. (2017). Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): Study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3195-7"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00259-015-3294-0","article-title":"18F-FDG PET\/CT quantification in head and neck squamous cell cancer: Principles, technical issues and clinical applications","volume":"43","author":"Manca","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1148\/radiol.2331030660","article-title":"Tumour volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen","volume":"233","author":"Daisne","year":"2004","journal-title":"Radiology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.clon.2012.09.004","article-title":"Variation in Radiotherapy Target Volume Definition, Dose to Organs at Risk and Clinical Target Volumes using Anatomic (Computed Tomography) versus Combined Anatomic and Molecular Imaging (Positron Emission Tomography\/Computed Tomography): Intensity-modulated Radiotherapy Delivered using a Tomotherapy Hi Art Machine: Final Results of the VortigERN Study","volume":"24","author":"Chatterjee","year":"2012","journal-title":"Clin. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2007.05.010","article-title":"Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: Impact on target volume delineation and dose distribution using helical tomotherapy","volume":"85","author":"Geets","year":"2007","journal-title":"Radiother. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ijrobp.2008.04.059","article-title":"Combined 18F-FDG-PET\/CT Imaging in Radiotherapy Target Delineation for Head-and-Neck Cancer","volume":"73","author":"Guido","year":"2009","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00066-021-01812-2","article-title":"Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN. Value of PET imaging for radiation therapy","volume":"197","author":"Lapa","year":"2021","journal-title":"Strahlenther. Onkol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00066-007-1663-8","article-title":"Locoregional failure analysis in head-and-neck cancer patients treated with IMRT","volume":"183","author":"Studer","year":"2007","journal-title":"Strahlenther. Onkol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8140(97)00079-0","article-title":"Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial","volume":"44","author":"Horiot","year":"1997","journal-title":"Radiother. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3109\/0284186X.2014.990109","article-title":"Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: A planning study","volume":"54","author":"Differding","year":"2015","journal-title":"Acta Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2020.08.006","article-title":"Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224)","volume":"151","author":"Mortensen","year":"2020","journal-title":"Radiother. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e934116","DOI":"10.12659\/MSM.934116","article-title":"Review of the Role of Hypoxia in Radioresistance in Cancer Therapy","volume":"27","author":"Bouleftour","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.radonc.2020.10.039","article-title":"18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: A phase I study (FiGaRO)","volume":"155","author":"Michaelidou","year":"2021","journal-title":"Radiother. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"110281","DOI":"10.1016\/j.radonc.2024.110281","article-title":"A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE)","volume":"196","author":"Giralt","year":"2024","journal-title":"Radiother. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Dolezel, M., Slavik, M., Blazek, T., Kazda, T., Koranda, P., Veverkova, L., Burkon, P., and Cvek, J. (2022). FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer. J. Pers. Med., 12.","DOI":"10.3390\/jpm12081245"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MNM.0000000000001329","article-title":"Positron emission tomography for radiotherapy planning in head and neck cancer: What impact?","volume":"42","author":"Flaus","year":"2021","journal-title":"Nucl. Med. Commun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1007\/s00330-023-09843-2","article-title":"Changes in serial multiparametric MRI and FDG-PET\/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer","volume":"33","author":"Trada","year":"2023","journal-title":"Eur. Radiol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"De Bruycker, A., De Neve, W., Daisne, J.F., Vercauteren, T., De Gersem, W., Olteanu, L., Berwouts, D., Deheneffe, S., Madani, I., and Goethals, I. (2024). Disease control and late toxicity in Adaptive Dose Painting by Numbers vs. non-adaptive radiotherapy for head and neck cancer: A randomized controlled phase II trial. Int. J. Radiat. Oncol. Biol. Phys.","DOI":"10.1016\/j.ijrobp.2024.01.012"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/lary.26268","article-title":"When should surveillance imaging be performed after treatment for head and neck cancer?","volume":"127","author":"Heineman","year":"2017","journal-title":"Laryngoscope"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00259-020-04710-4","article-title":"Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy: Results from the ECLYPS study","volume":"47","author":"Helsen","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/0194599815621742","article-title":"Detecting Residual\/Recurrent Head Neck Squamous Cell Carcinomas Using PET or PET\/CT: Systematic Review and Meta-analysis","volume":"154","author":"Cheung","year":"2016","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/157488712799363226","article-title":"Positron emission tomography for neck evaluation following definitive treatment with chemoradiotherapy for locoregionally advanced head and neck squamous cell carcinoma","volume":"7","author":"Mishra","year":"2012","journal-title":"Rev. Recent Clin. Trials"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2012.03.001","article-title":"Can \u201cearly\u201d and \u201clate\u201d 18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?","volume":"103","author":"Castaldi","year":"2012","journal-title":"Radiother. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0022-3468(88)80378-6","article-title":"Surgical management of the cleft sternum","volume":"23","author":"Mogilner","year":"1988","journal-title":"J. Pediatr. Surg."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2967\/jnumed.113.136796","article-title":"Head and neck PET\/CT: Therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes","volume":"55","author":"Marcus","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jacr.2015.09.032","article-title":"Implementation of a Novel Surveillance Template for Head and Neck Cancer: Neck Imaging Reporting and Data System (NI-RADS)","volume":"13","author":"Aiken","year":"2016","journal-title":"J. Am. Coll. Radiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1038\/s41598-020-60739-3","article-title":"Post-treatment FDG PET-CT in head and neck carcinoma: Comparative analysis of 4 qualitative interpretative criteria in a large patient cohort","volume":"10","author":"Zhong","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijrobp.2017.02.217","article-title":"Interim 18F-FDG PET\/CT During Chemoradiation Therapy in the Management of Head and Neck Cancer Patients: A Systematic Review","volume":"98","author":"Garibaldi","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00259-011-1759-3","article-title":"Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer","volume":"38","author":"Hentschel","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/lary.24826","article-title":"Interim FDG PET\/CT for predicting the outcome in patients with head and neck cancer","volume":"124","author":"Chen","year":"2014","journal-title":"Laryngoscope"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/lary.23941","article-title":"PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient","volume":"123","author":"Dunsky","year":"2013","journal-title":"Laryngoscope"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/jamaoncol.2017.0973","article-title":"Patterns of Treatment Failure and Postrecurrence Outcomes among Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques","volume":"3","author":"Leeman","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/hed.23108","article-title":"Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma","volume":"35","author":"Pryor","year":"2013","journal-title":"Head Neck"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/1097-0142(20011101)92:9<2341::AID-CNCR1581>3.0.CO;2-8","article-title":"The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck","volume":"92","author":"Hollenbeak","year":"2001","journal-title":"Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/annonc\/mdp405","article-title":"Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer","volume":"21","author":"Sher","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/lary.22464","article-title":"A cost-effectiveness analysis of positron emission tomography-computed tomography surveillance versus up-frontneck dissection for management of the neck for N2 disease after chemoradiotherapy","volume":"122","author":"Rabalais","year":"2012","journal-title":"Laryngoscope"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejca.2017.07.054","article-title":"Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer","volume":"85","author":"Smith","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1874471008666150316222400","article-title":"Hypoxia PET Tracers in EBRT Dose Planning in Head and Neck Cancer","volume":"8","author":"Fettich","year":"2015","journal-title":"Curr. Radiopharm."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrc2540","article-title":"The impact of O2 availability on human cancer","volume":"8","author":"Bertout","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13014-017-0776-1","article-title":"Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol","volume":"12","author":"Pigorsch","year":"2017","journal-title":"Radiat. Oncol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2967\/jnmt.120.249540","article-title":"PET\/CT in the Evaluation of Hypoxia for Radiotherapy Planning in Head and Neck Tumors: Systematic Literature Review","volume":"49","author":"Lopes","year":"2021","journal-title":"J. Nucl. Med. Technol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.radonc.2017.04.004","article-title":"Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial","volume":"124","author":"Welz","year":"2017","journal-title":"Radiother. Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3109\/0284186X.2015.1074720","article-title":"Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure","volume":"54","author":"Zschaeck","year":"2015","journal-title":"Acta Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/0284186X.2017.1372626","article-title":"Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer","volume":"56","author":"Boeke","year":"2017","journal-title":"Acta Oncol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2015.09.015","article-title":"Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome","volume":"117","author":"Wiedenmann","year":"2015","journal-title":"Radiother. Oncol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2006.07.033","article-title":"Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients","volume":"80","author":"Thorwarth","year":"2006","journal-title":"Radiother. Oncol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","author":"Chen","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Rizzo, A., Miceli, A., Racca, M., Bauckneht, M., Morbelli, S., Albano, D., Dondi, F., Bertagna, F., Galizia, D., and Muoio, B. (2023). Diagnostic Accuracy of [68Ga]Ga Labeled Fibroblast-Activation Protein Inhibitors in Detecting Head and Neck Cancer Lesions Using Positron Emission Tomography: A Systematic Review and a Meta-Analysis. Pharmaceuticals, 16.","DOI":"10.3390\/ph16121664"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1007\/s00259-021-05336-w","article-title":"Clinical utility of [68Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography\/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma","volume":"48","author":"Zhao","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1007\/s00259-021-05422-z","article-title":"Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity\u2014Initial experience and comparison to [18F]FDG PET\/CT and MRI","volume":"48","author":"Linz","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s11307-010-0318-9","article-title":"A study on the prognostic evaluation of carbon ion radiotherapy for head and neck adenocarcinoma with C-11 methionine PET","volume":"12","author":"Hasebe","year":"2010","journal-title":"Mol. Imaging Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1748-717X-8-143","article-title":"Accuracy of methionine-PET in predicting the efficacy of heavy-particle therapy on primary adenoid cystic carcinomas of the head and neck","volume":"8","author":"Toubaru","year":"2013","journal-title":"Radiat. Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.ijom.2017.04.019","article-title":"Usefulness of 11C-methionine-PET for predicting the efficacy of carbon ion radiation therapy for head and neck mucosal malignant melanoma","volume":"46","author":"Hasebe","year":"2017","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_140","first-page":"256","article-title":"18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer","volume":"47","author":"Pauleit","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s11307-010-0419-5","article-title":"18F-FET PET\/CT in advanced head and neck squamous cell carcinoma: An intra-individual comparison with 18F-FDG PET\/CT","volume":"13","author":"Haerle","year":"2011","journal-title":"Mol. Imaging Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11307-008-0155-2","article-title":"Prospective comparison of FDG and FET PET\/CT in patients with head and neck squamous cell carcinoma","volume":"10","author":"Balogova","year":"2008","journal-title":"Mol. Imaging Biol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0300891619868012","article-title":"Assessment of biological parameters in head and neck cancer based on in vivo distribution of 18F-FDG-FLT-FMISO-PET\/CT images","volume":"106","author":"Cegla","year":"2020","journal-title":"Tumori J."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s12149-014-0902-1","article-title":"Predictive value of SUV-based parameters derived from pre-treatment 18F-FLT PET\/CT for short-term outcome with head and neck cancers","volume":"28","author":"Hoshikawa","year":"2014","journal-title":"Ann. Nucl. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.joms.2015.01.002","article-title":"Can 3\u2032-Deoxy-3\u2032-(18F) Fluorothymidine Outperform 2-Deoxy-2-(18F) Fluoro-D-Glucose Positron Emission Tomography\/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients with Oral\/Head and Neck Cancer?","volume":"73","author":"Schaefferkoetter","year":"2015","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e210088","DOI":"10.1148\/rycan.210088","article-title":"Head and Neck Paragangliomas: An Update on the Molecular Classification, State-of-the-Art Imaging, and Management Recommendations","volume":"4","author":"Lin","year":"2022","journal-title":"Radiol. Imaging Cancer"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","article-title":"Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma","volume":"21","author":"Janssen","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2967\/jnumed.112.115485","article-title":"68Ga-DOTANOC PET\/CT for baseline evaluation of patients with head and neck paraganglioma","volume":"54","author":"Sharma","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_149","unstructured":"National Comprehensive Cancer Network (2024, March 25). NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine and Adrenal Tumors. NCCN Version 1. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/neuroendocrine.pdf."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Hicks","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2967\/jnumed.118.211706","article-title":"Performance of 68Ga-DOTA-Conjugated Somatostatin Receptor-Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis","volume":"60","author":"Han","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/hed.24783","article-title":"Local resectability assessment of head and neck cancer: Positron emission tomography\/MRI versus positron emission tomography\/CT","volume":"39","author":"Sekine","year":"2017","journal-title":"Head Neck"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/RLU.0b013e318217566f","article-title":"A comparative study of fused FDG PET\/MRI, PET\/CT, MRI, and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma","volume":"36","author":"Huang","year":"2011","journal-title":"Clin. Nucl. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ejrad.2015.04.010","article-title":"Simultaneous PET\/MRI head\u2013neck cancer imaging: Preliminary clinical experience and multiparametric evaluation","volume":"84","author":"Covello","year":"2015","journal-title":"Eur. J. Radiol."},{"key":"ref_155","first-page":"515","article-title":"Comparison of contrast enhanced PET\/MRI and contrast enhanced PET\/CT in patients with head and neck cancer","volume":"54","author":"Kuhn","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejrad.2016.12.034","article-title":"Multiparametric evaluation by simultaneous PET-MRI examination in patients with histologically proven laryngeal cancer","volume":"88","author":"Cavaliere","year":"2017","journal-title":"Eur. J. Radiol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2967\/jnumed.113.125443","article-title":"Contrast-enhanced PET\/MR imaging versus contrast-enhanced PET\/CT in head and neck cancer: How much MR information is needed?","volume":"55","author":"Kuhn","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.semnuclmed.2020.07.006","article-title":"PET\/MR in Head and Neck Cancer\u2014An Update","volume":"51","author":"Huellner","year":"2021","journal-title":"Semin. Nucl. Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/MNM.0000000000001174","article-title":"Fluoro-deoxy-glucose uptake in the mylohyoid muscle: A common misconception","volume":"41","author":"Pizzuto","year":"2020","journal-title":"Nucl. Med. Commun."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1102\/1470-7330.2013.0001","article-title":"Physiologic [18F]fluorodeoxyglucose uptake of floor of mouth muscles in PET\/CT imaging: A problem of body position during FDG uptake?","volume":"13","author":"Haerle","year":"2013","journal-title":"Cancer Imaging"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2634389","DOI":"10.1155\/2017\/2634389","article-title":"An evaluation of the benefits of simultaneous acquisition on PET\/MR coregistration in head\/neck imaging","volume":"2017","author":"Monti","year":"2017","journal-title":"J. Healthc. Eng."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00259-018-3986-3","article-title":"Clinical utility of simultaneous whole-body 18F-FDG PET\/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma","volume":"45","author":"Chan","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_163","first-page":"177","article-title":"Preliminary clinical results for PET\/MR compared with PET\/CT in patients with nasopharyngeal carcinoma","volume":"43","author":"Cheng","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/RCT.0000000000001036","article-title":"Comparative study between integrated positron emission tomography\/magnetic resonance and positron emission tomography\/computed tomography in the T and N staging of hypopharyngeal cancer: An initial result","volume":"44","author":"Huang","year":"2020","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jmri.28842","article-title":"Use of 18F-FDG PET\/MRI as an Initial Staging Procedure for Nasopharyngeal Carcinoma","volume":"59","author":"Cao","year":"2024","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3174\/ajnr.A3993","article-title":"Qualitative and quantitative performance of 18F-FDG-PET\/MRI versus 18F-FDG-PET\/CT in patients with head and neck cancer","volume":"35","author":"Partovi","year":"2014","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00259-013-2633-2","article-title":"Initial clinical results of simultaneous 18F-FDG PET\/MRI in comparison to 18F-FDG PET\/CT in patients with head and neck cancer","volume":"41","author":"Kubiessa","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.clinimag.2017.01.003","article-title":"PET+MR versus PET\/CT in the initial staging of head and neck cancer, using a trimodality PET\/CT+MR system","volume":"42","author":"Sekine","year":"2017","journal-title":"Clin. Imaging"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ejrad.2014.03.023","article-title":"FDG PET\/MR for lymph node staging in head and neck cancer","volume":"83","author":"Platzek","year":"2014","journal-title":"Eur. J. Radiol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00259-015-3145-z","article-title":"Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: A comparison between MRI, PET\/CT and integrated PET\/MRI","volume":"43","author":"Schaarschmidt","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00259-013-2580-y","article-title":"Detection and quantification of focal uptake in head and neck tumours: 18F-FDG PET\/MR versus PET\/CT","volume":"41","author":"Varoquaux","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/RLI.0b013e31826f2de9","article-title":"Detection rate, location, and size of pulmonary nodules in trimodality PET\/CT-MR: Comparison of low-dose CT and Dixon-based MR imaging","volume":"48","author":"Stolzmann","year":"2013","journal-title":"Investig. Radiol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/jmri.25005","article-title":"Outcome of small lung nodules missed on hybrid PET\/MRI in patients with primary malignancy","volume":"43","author":"Raad","year":"2016","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/SLA.0000000000000719","article-title":"Natural history of preoperative subcentimeter pulmonary nodules in patients with resectable pancreatic adenocarcinoma: A retrospective cohort study","volume":"261","author":"Chang","year":"2015","journal-title":"Ann. Surg."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1097\/RLU.0000000000001461","article-title":"PET\/MR Outperforms PET\/CT in Suspected Occult Tumors","volume":"42","author":"Sekine","year":"2017","journal-title":"Clin. Nucl. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.ejrad.2016.08.020","article-title":"Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET\/MRI versus PET\/CT","volume":"85","author":"Ruhlmann","year":"2016","journal-title":"Eur. J. Radiol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00066-019-01480-3","article-title":"PET\/MRI-guided GTV delineation during radiotherapy planning in patients with squamous cell carcinoma of the tongue","volume":"195","author":"Sierko","year":"2019","journal-title":"Strahlenther. Onkol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fonc.2017.00008","article-title":"Evaluation of PET\/MRI for Tumor Volume Delineation for Head and Neck Cancer","volume":"7","author":"Wang","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"109484","DOI":"10.1016\/j.radonc.2023.109484","article-title":"Tumor volume definitions in head and neck squamous cell carcinoma\u2014Comparing PET\/MRI and histopathology","volume":"180","author":"Terzidis","year":"2023","journal-title":"Radiother. Oncol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/hed.25485","article-title":"18F-FDG PET\/MRI vs MRI in patients with recurrent adenoid cystic carcinoma","volume":"41","author":"Kirchner","year":"2019","journal-title":"Head Neck"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00330-017-4999-1","article-title":"Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET\/MRI with diffusion-weighted sequences","volume":"28","author":"Becker","year":"2018","journal-title":"Eur. Radiol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1007\/s00259-014-2867-7","article-title":"Use of diffusion-weighted imaging (DWI) in PET\/MRI for head and neck cancer evaluation","volume":"41","author":"Queiroz","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.semnuclmed.2014.12.005","article-title":"PET\/MR in cancers of the head and neck","volume":"45","author":"Queiroz","year":"2015","journal-title":"Semin. Nucl. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.critrevonc.2016.10.009","article-title":"Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy","volume":"108","author":"Castelli","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Zhang, W., Guo, Y., and Jin, Q. (2023). Radiomics and Its Feature Selection: A Review. Symmetry, 15.","DOI":"10.3390\/sym15101834"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejmp.2017.05.071","article-title":"Beyond imaging: The promise of radiomics","volume":"38","author":"Avanzo","year":"2017","journal-title":"Phys. Medica"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/jop.13135","article-title":"Comparison of machine learning algorithms for the prediction of five-year survival in oral squamous cell carcinoma","volume":"50","author":"Alkhadar","year":"2021","journal-title":"J. Oral Pathol. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hed.25433","article-title":"Prognostic value of textural indices extracted from pretherapeutic 18-F-FDG-PET\/CT in head and neck squamous cell carcinoma","volume":"41","author":"Guezennec","year":"2019","journal-title":"Head Neck"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"3574310","DOI":"10.1155\/2018\/3574310","article-title":"Radiomic Profiling of Head and Neck Cancer: 18F-FDG PET Texture Analysis as Predictor of Patient Survival","volume":"2018","author":"Feliciani","year":"2018","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.radonc.2017.10.023","article-title":"Post-radiochemotherapy PET radiomics in head and neck cancer\u2014The influence of radiomics implementation on the reproducibility of local control tumor models","volume":"125","author":"Bogowicz","year":"2017","journal-title":"Radiother. Oncol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1080\/0284186X.2017.1346382","article-title":"Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma","volume":"56","author":"Bogowicz","year":"2017","journal-title":"Acta Oncol."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Song, Y., Tian, Y., Lu, X., Chen, G., and Lv, X. (2024). Prognostic value of 18F-FDG PET radiomics and sarcopenia in patients with oral squamous cell carcinoma. Med. Phys.","DOI":"10.1002\/mp.16949"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Choi, J.H., Choi, J.Y., Woo, S.K., Moon, J.E., Lim, C.H., Park, S.B., Seo, S., Ahn, Y.C., Ahn, M.J., and Moon, S.H. (2024). Prognostic Value of Radiomic Analysis Using Pre- and Post-Treatment 18F-FDG-PET\/CT in Patients with Laryngeal Cancer and Hypopharyngeal Cancer. J. Pers. Med., 14.","DOI":"10.3390\/jpm14010071"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11282-022-00600-7","article-title":"Radiomics analysis of [18F]-fluoro-2-deoxyglucose positron emission tomography for the prediction of cervical lymph node metastasis in tongue squamous cell carcinoma","volume":"39","author":"Kudoh","year":"2023","journal-title":"Oral Radiol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"100906","DOI":"10.1016\/j.tranon.2020.100906","article-title":"Prediction of post-radiotherapy locoregional progression in HPV-associated oropharyngeal squamous cell carcinoma using machine-learning analysis of baseline PET\/CT radiomics","volume":"14","author":"Haider","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11307-022-01757-7","article-title":"The usefulness of machine learning-based evaluation of clinical and pretreatment [18F]-FDG-PET\/CT radiomic features for predicting prognosis in hypopharyngeal cancer","volume":"25","author":"Nakajo","year":"2023","journal-title":"Mol. Imaging Biol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1002\/mp.14926","article-title":"Intrinsic radiomic expression patterns after 20 Gy demonstrate early metabolic response of oropharyngeal cancers","volume":"48","author":"Lafata","year":"2021","journal-title":"Med. Phys."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00259-022-05973-9","article-title":"Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer","volume":"50","author":"Spielvogel","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Haider, S.P., Zeevi, T., Baumeister, P., Reichel, C., Sharaf, K., Forghani, R., Kann, B.H., Judson, B.L., Prasad, M.L., and Burtness, B. (2020). Potential added value of PET\/CT radiomics for survival prognostication beyond AJCC 8th edition staging in oropharyngeal squamous cell carcinoma. Cancers, 12.","DOI":"10.3390\/cancers12071778"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"78.e9","DOI":"10.1016\/j.crad.2020.08.030","article-title":"Machine learning-based FDG PET-CT radiomics for outcome prediction in larynx and hypopharynx squamous cell carcinoma","volume":"76","author":"Zhong","year":"2021","journal-title":"Clin. Radiol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s11307-019-01411-9","article-title":"Machine learning methods for optimal radiomics-based differentiation between recurrence and inflammation: Application to nasopharyngeal carcinoma post-therapy PET\/CT images","volume":"22","author":"Du","year":"2020","journal-title":"Mol. Imaging Biol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1158\/1078-0432.CCR-18-3065","article-title":"Prognostic value of deep learning PET\/CT-based radiomics: Potential role for future individual induction chemotherapy in advanced nasopharyngeal carcinoma","volume":"25","author":"Peng","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11604-023-01476-1","article-title":"Clinical application of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography radiomics-based machine learning analyses in the field of oncology","volume":"42","author":"Nakajo","year":"2024","journal-title":"Jpn. J. Radiol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"20220772","DOI":"10.1259\/bjr.20220772","article-title":"The usefulness of machine-learning-based evaluation of clinical and pretreatment 18F-FDG-PET\/CT radiomic features for predicting prognosis in patients with laryngeal cancer","volume":"96","author":"Nakajo","year":"2023","journal-title":"Br. J. Radiol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s11307-019-01439-x","article-title":"Subregional Radiomics Analysis of PET\/CT Imaging with Intratumor Partitioning: Application to Prognosis for Nasopharyngeal Carcinoma","volume":"22","author":"Xu","year":"2020","journal-title":"Mol. Imaging Biol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"711.e1","DOI":"10.1016\/j.crad.2021.03.017","article-title":"Prediction of the treatment outcome using machine learning with FDG-PET image-based multiparametric approach in patients with oral cavity squamous cell carcinoma","volume":"76","author":"Fujima","year":"2021","journal-title":"Clin. Radiol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1007\/s00330-020-06982-8","article-title":"Deep learning analysis using FDG-PET to predict treatment outcome in patients with oral cavity squamous cell carcinoma","volume":"30","author":"Fujima","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijrobp.2019.01.077","article-title":"Tumor Voxel Dose-Response Matrix and Dose Prescription Function Derived Using 18F-FDG PET\/CT Images for Adaptive Dose Painting by Number","volume":"104","author":"Yan","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Reiazi, R., Abbas, E., Famiyeh, P., Rezaie, A., Kwan, J.Y.Y., Patel, T., Bratman, S.V., Tadic, T., and Liu, F.F. (2021). The impact of the variation of imaging parameters on the robustness of Computed Tomography radiomic features: A review. Comput. Biol. Med., 133.","DOI":"10.1016\/j.compbiomed.2021.104400"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1080\/0284186X.2017.1351624","article-title":"Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: A comprehensive phantom study","volume":"56","author":"Larue","year":"2017","journal-title":"Acta Oncol."},{"key":"ref_211","first-page":"100590","article-title":"Artificial intelligence to predict outcomes of head and neck radiotherapy","volume":"39","author":"Bang","year":"2023","journal-title":"Clin. Transl. Radiat. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/10\/1905\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:43:35Z","timestamp":1760107415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/10\/1905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":211,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["cancers16101905"],"URL":"https:\/\/doi.org\/10.3390\/cancers16101905","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]}}}